Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Interest Coverage Ratio: 2022-2025

Historic Interest Coverage Ratio for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to 2.78.

  • Arcutis Biotherapeutics' Interest Coverage Ratio rose 147.28% to 2.78 in Q3 2025 from the same period last year, while for Sep 2025 it was -2.61, marking a year-over-year increase of 57.79%. This contributed to the annual value of -4.73 for FY2024, which is 41.76% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Interest Coverage Ratio stood at 2.78 for Q3 2025, which was up 157.56% from -4.82 recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Interest Coverage Ratio high stood at 2.78 for Q3 2025, and its period low was -34.07 during Q1 2022.
  • Its 3-year average for Interest Coverage Ratio is -5.56, with a median of -5.87 in 2024.
  • Data for Arcutis Biotherapeutics' Interest Coverage Ratio shows a peak YoY increase of 147.28% (in 2025) and a maximum YoY decrease of 94.57% (in 2025) over the last 5 years.
  • Over the past 4 years, Arcutis Biotherapeutics' Interest Coverage Ratio (Quarterly) stood at -9.90 in 2022, then climbed by 20.36% to -7.88 in 2023, then surged by 82.55% to -1.37 in 2024, then spiked by 147.28% to 2.78 in 2025.
  • Its last three reported values are 2.78 in Q3 2025, -4.82 for Q2 2025, and -8.23 during Q1 2025.